Spotlight Stock,Trends & Articles HaluGen Life Sciences Enters Into an Agreement With Psychedelics Today By Dennis Mutua January 19, 2022 Genetic based psychedelic pre-screening platform focusing on evaluating sensitivity and the risk profile when one is using hallucinogenic drugs HaluGen Life Sciences Inc. announced having entered in an agreement with Psychedelic T...
Featured,Trends & Articles Filament Health and Cybin Therapeutics Enters Into a Licensing Agreement By Dennis Mutua January 18, 2022 Clinical-stage natural psychedelic drug development company supporting treatment of mental health conditions Filament Health Corp. (NEO: FH) (OTCQB: FHLLF) announced having entered into a licensing agreement with Cybin Therapeutic...
Spotlight Stock,Trends & Articles Mydecine to Launch SASSP in Canada to Expand Patients’ Access to Psychedelic-Assisted Psychotherapy By Dennis Mutua January 14, 2022 Biotechnology company specializing in research, development and acceptance of naturally extracted medicine for clinical management and mental wellness Mydecine Innovations Group Inc. (NEO: MYCO) (OTCMKTS: MYCOF) announced that it ...
Spotlight Stock,Trends & Articles MYND Life Sciences Enters Into a Research Agreement With University of British Columbia By Dennis Mutua January 13, 2022 Neuro-pharmaceutical company drug development company advancing medicines that leverage on psychedelic compounds Mynd Life Sciences Inc. (CSE: MYND) (OTCMKTS: MYNDF) has entered into a collaborative research agreement with Unive...
Featured,Trends & Articles FDA Grants Wesana Health Pre-IND Meeting For SANA-013 By Dennis Mutua January 12, 2022 Emerging life sciences company specializing in development and delivery of psychedelic and naturally extracted therapies to treat traumatic brain injuries Wesana Health Holdings Inc. (CSE: WESA) (OTCQB: WSNAF) announced having bee...
Spotlight Stock,Trends & Articles Levitee Labs Announces Formation of Medical Advisory Board By Dennis Mutua January 07, 2022 Multidisciplinary wellness company focused on redefining traditional mental health and addiction treatments through novel psychedelics therapies Levitee Labs Inc. (CSE: LVT) (OTCMKTS: LVTTF) has announced formation of a Medical Ad...
Spotlight Stock,Trends & Articles McQuade Center for Strategic Research Partners With Mindset Pharma to Develop Psychedelics Medicines By Dennis Mutua January 06, 2022 Biotechnology company focusing on discovering and developing next-generation psychedelic medicines Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) has entered into a partnership with The McQuade Center for Strategic Research and De...
Spotlight Stock,Trends & Articles Delic CEO Joins Shares His Views on Evolution of Psychedelics Industry in a Podcast By Dennis Mutua January 04, 2022 Matt Stang, the chief executive officer of psychedelic wellness company focusing on bringing safe, legal and science-backed benefits to all Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) joined the Gamechangers Live podcast where...